Episode Details

Back to Episodes
InnoCare Pharma Yinuokai (Obutinib) has added first-line CLL/SLL indications and will be

InnoCare Pharma Yinuokai (Obutinib) has added first-line CLL/SLL indications and will be

Published 11 months ago
Description
Smf5Yv7iSAZW7lGwgunC
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us